<DOC>
	<DOCNO>NCT00191022</DOCNO>
	<brief_summary>This study Phase 2 trial test efficacy LY686017 treatment Social Anxiety Disorder .</brief_summary>
	<brief_title>Comparison LY686017 With Marketed Drug Treatment Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Male female outpatient least 18 year age 65 year age . Must sign inform consent document . Present Visit 1 social anxiety disorder base Clinical Global ImpressionSeverity score great equal 4 . Females childbearing potential ( surgically sterilize menarche 1 year postmenopause ) must test negative pregnancy time enrollment base urine pregnancy test agree use reliable primary method birth control . Judged reliable willing keep appointment clinic visit , test , procedure require protocol . Have comorbid Axis I disorder ( major depression , obsessive compulsive disorder , posttraumatic stress disorder , panic disorder ) , opinion investigator , disorder occur within last 6 month . Have previous current diagnosis bipolar disorder , schizophrenia , psychotic disorder . Have presence Axis II disorder , except avoidant personality disorder . Have serious medical illness . Have abnormal thyroidstimulating hormone ( TSH ) concentration take thyroid supplement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>